Filters

ARSA Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

ARSA Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) size: 1.0 µg DNA 322

Supplier ABM LENTIVECTORS
Price 322
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetARSA Lentiviral Vector (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Short nameARSA Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-Red Fluorescent-2A-Puro), ARSA Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 713
Gene ARSA
Long gene name arylsulfatase A
Synonyms name metachromatic leucodystrophy
Locus 22q13, 33
Discovery year 1986-01-01
GenBank acession X52150
Entrez gene record 410
Pubmed identfication 15772092
RefSeq identity NM_000487
Classification Sulfatases
Havana BLAST/BLAT OTTHUMG00000150180

Similar products

Subscribe to our Newsletter